Key result
Macrophage-specific IKKα knockout worsens doxorubicin-induced cardiac dysfunction and fibrosis in mice.
Why the study?
Doxorubicin-induced cardiomyopathy causes severe cardiac impairment, and while immune cells are implicated in cardiovascular inflammation, the underlying molecular mechanisms remain unclear.
Does macrophage-specific IKKα knockout exacerbate doxorubicin-induced cardiomyopathy in mice?
Does macrophage-specific IKKα knockout exacerbate doxorubicin-induced cardiomyopathy in mice?
Macrophage-specific IKKα knockout exacerbates early-stage doxorubicin-induced cardiomyopathy by promoting a pro-inflammatory M1 macrophage shift and altering T cell interactions.
Macrophage IKKα may protect against doxorubicin cardiotoxicity in mice; hypothesis-generating for targeted therapies pending human validation.
Doxorubicin (DOX) is a chemotherapeutic agent used to treat solid tumors and hematologic malignancies, though DOX-induced cardiomyopathy poses a risk of severe cardiac impairment and poor prognosis. Immune cells have been increasingly implicated in cardiovascular inflammation, with overproduction of inflammatory cytokines and macrophage accumulation. However, its molecular mechanism remains unclear and needs to be further investigated. This study investigated the involvement of IKKα in regulating cardiac function in response to early-stage DOX stimulation. Results indicated that IKKαLyz2-Cre mice were more susceptible to DOX-induced cardiac injury than IKKαflox/flox mice, showing reduced heart function, extensive cardiac fibrosis, and elevated inflammatory markers. Single-cell transcriptomic analysis revealed cellular heterogeneity in DOX-induced cardiomyopathy tissue between IKKαflox/flox and IKKαLyz2-Cre mice, identifying 11 cell types, 8 of which were immune cells. Bar plots and cell density analysis showed a higher proportion of T cells in IKKαflox/floxmice, while IKKαLyz2-Cre mice had increased monocytes and macrophages. Notably, IKKα deletion promoted a shift in macrophage polarization from Fcna⁺ M2 to Jaml⁺ M1 and impaired T cell activation and differentiation. Additionally, IKKα played a critical role in mediating macrophage-T cell interactions. Loss of macrophage IKKα activated T cells through Jaml⁺ M1 macrophage, and activated T cells subsequently enhanced M1 macrophage activation via IFN-γ and IL-6. These findings highlight the potential of targeting immune cell interactions as a therapeutic strategy.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied Doxorubicin-induced cardiomyopathy in mouse model. Macrophage-specific IKKα knockout (IKKα Lyz2-Cre) vs IKKα flox/flox control vs. IKKα flox/flox mice with same DOX dosing was evaluated on Cardiac function assessed by left ventricular ejection fraction (EF%) and fractional shortening (FS%), cardiac fibrosis, inflammatory cytokine levels. Macrophage-specific IKKα knockout mice showed greater early decline in cardiac function, increased fibrosis, and elevated inflammatory markers compared to control mice after doxorubicin administration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: